Moreover, retrospective data suggest the high dose glucocorticoids sometimes used in new-onset ICI-IA may be associated with worse cancer outcomes.Tumour necrosis factor (TNF) inhibition strategies are well established with excellent efficacy and safety profiles in 'spontaneous' inflammatory arthritides including rheumatoid and psoriatic arthritis. Here, TNF is linked to cancer.